EP3129063 - Bibliographic data
CONJUGUÉ MÉDICAMENT-ANTICORPS ANTI-HER3
| Last update | 21/05/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
Daiichi Sankyo Company, Limited 3-5-1, Nihonbashi Honcho
Chuo-ku
Tokyo 103-8426
Japon
Daiichi Sankyo Europe GmbH Zielstattstr. 48
81379 München
Allemagne
|
|---|---|
| (72) Inventors |
Thore HETTMANN c/o U3 Pharma GmbH
Fraunhoferstr. 22
82152 Martinsried
Allemagne
Reimar ABRAHAM c/o U3 Pharma GmbH
Fraunhoferstr. 22
82152 Martinsried
Allemagne
Sabine BLUM c/o U3 Pharma GmbH
Fraunhoferstr. 22
82152 Martinsried
Allemagne
Suguru UENO c/o DAIICHI SANKYO COMPANY,
LIMITED
1-2-58 Hiromachi
Shinagawa-ku
Tokyo 140-8710
Japon
|
| (74) Agent |
Mail recipient
MARKS & CLERK LLP 44, Rue de la Vallée - BP 1775
1017
LUXEMBOURG
Luxembourg
|
| (21) Request number | EP15719011.7 |
|---|---|
| (22) Request date | 10/04/2015 |
| (11) Publication number | EP3129063 |
|---|---|
| Publication date | 27/01/2021 |
| (54) Title of the invention | CONJUGUÉ MÉDICAMENT-ANTICORPS ANTI-HER3 |
|---|---|
| (51) International classification | A61K 47/68, A61P 35/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: 2014081454 |
|---|---|
| Initial application | None |
| Divisional application | EP20200710.0 /EP3789042 None |
| Expected annuity | Annuity: 12 - Amount: 285 € - Due date 30/04/2026 |
|---|---|
| Last annuity | Annuity: 11 - Payment date 27/03/2025 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 27/01/2021 Constitution de mandataire pour un dossier - Legal date 14/04/2021 |